Cargando…

InSilc Computational Tool for In Silico Optimization of Drug-Eluting Bioresorbable Vascular Scaffolds

Stents made by different manufacturers must meet the requirements of standard in vitro mechanical tests performed under different physiological conditions in order to be validated. In addition to in vitro research, there is a need for in silico numerical simulations that can help during the stent pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milosevic, Miljan, Anic, Milos, Nikolic, Dalibor, Milicevic, Bogdan, Kojic, Milos, Filipovic, Nenad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467806/ https://www.ncbi.nlm.nih.gov/pubmed/36105243 http://dx.doi.org/10.1155/2022/5311208

Ejemplares similares

Application of in silico Platform for the Development and Optimization of Fully Bioresorbable Vascular Scaffold Designs
por: Milosevic, Miljan, et al.
Publicado: (2021)

Simulated versus physical bench tests: The economic evaluation of the InSilc platform for designing, developing, and assessing vascular scaffolds
por: Mincarone, Pierpaolo, et al.
Publicado: (2021)

Smeared Multiscale Finite Element Models for Mass Transport and Electrophysiology Coupled to Muscle Mechanics
por: Kojic, Milos, et al.
Publicado: (2019)

Machine learning and physical based modeling for cardiac hypertrophy
por: Milićević, Bogdan, et al.
Publicado: (2023)

Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent
por: Dalos, Daniel, et al.
Publicado: (2016)

A Computational Model for Drug Release from PLGA Implant
por: Milosevic, Miljan, et al.
Publicado: (2018)

Chronic total occlusion successfully treated with a bioresorbable everolimus-eluting vascular scaffold
por: Rama-Merchan, Juan Carlos, et al.
Publicado: (2014)

Preparation and modeling of three‐layered PCL/PLGA/PCL fibrous scaffolds for prolonged drug release
por: Milosevic, Miljan, et al.
Publicado: (2020)

Author Correction: Preparation and modeling of three‐layered PCL/PLGA/PCL fibrous scaffolds for prolonged drug release
por: Milosevic, Miljan, et al.
Publicado: (2021)

Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience
por: Remkes, W. S., et al.
Publicado: (2017)

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice
por: Lee, Joo Myung, et al.
Publicado: (2023)

Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
por: Cakal, Beytullah, et al.
Publicado: (2020)

First-in-man Implantation of the XINSORB Bioresorbable Sirolimus-eluting Scaffold in China
por: Chen, Jia-Hui, et al.
Publicado: (2015)

Vascular restoration therapy and bioresorbable vascular scaffold
por: Wang, Yunbing, et al.
Publicado: (2014)

Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent
por: Barkholt, Trine Ø., et al.
Publicado: (2019)

Long-Term Follow-Up of Patients after Percutaneous Coronary Intervention with Everolimus-Eluting Bioresorbable Vascular Scaffold
por: Meneguz-Moreno, Rafael Alexandre, et al.
Publicado: (2017)

Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease
por: Campos, Carlos M., et al.
Publicado: (2013)

Bioresorbable vascular scaffolds: between promises and reality
por: Montone, Rocco A., et al.
Publicado: (2017)

Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
por: Desperak, Piotr, et al.
Publicado: (2020)

Five‐year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus‐eluting coronary stents with everolimus‐eluting bioresorbable vascular scaffolds
por: Schukraft, Sara, et al.
Publicado: (2021)

Computational Modeling on Drugs Effects for Left Ventricle in Cardiomyopathy Disease
por: Tomasevic, Smiljana, et al.
Publicado: (2023)

Coronary Artery Vessel Healing Pattern, Short and Long Term, After Implantation of the Everolimus‐Eluting Bioresorbable Vascular Scaffold
por: Kraak, Robin P., et al.
Publicado: (2015)

SILC for SILC: Single Institution Learning Curve for Single-Incision Laparoscopic Cholecystectomy
por: Tay, Chee Wei, et al.
Publicado: (2013)

The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective
por: Kawashima, H., et al.
Publicado: (2020)

Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial
por: Arroyo, Diego, et al.
Publicado: (2014)

Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
por: Brugaletta, Salvatore, et al.
Publicado: (2011)

Three-year outcomes of bioresorbable vascular scaffolds versus second-generation drug-eluting stents: Meta-analysis of randomized trials
por: Ke, Junsong, et al.
Publicado: (2020)

Clinical presentation does not affect acute mechanical performance of the Novolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography
por: Boeder, Niklas F., et al.
Publicado: (2021)

Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials
por: Jackson-Smith, Elliot, et al.
Publicado: (2022)

Drug-eluting, balloon-expandable, bioresorbable vascular scaffolds reduce neointimal thickness and stenosis in an animal model of percutaneous peripheral intervention
por: El Khoury, Rym, et al.
Publicado: (2023)

Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis
por: Goncalves-Ramírez, Luis R., et al.
Publicado: (2019)

Bioresorbable vascular scaffold: promises and the fallen child-as-king?
por: Cook, Stephane, et al.
Publicado: (2016)

Bioresorbable Vascular Scaffold Korean Expert Panel Report
por: Ahn, Jung-Min, et al.
Publicado: (2017)

Very-long-term efficacy of bioresorbable vascular scaffolds
por: Shah, R.
Publicado: (2017)

Neoatherosclerosis　― Long-Term Assessment of Bioresorbable Vascular Scaffold ―
por: Moriyama, Noriaki, et al.
Publicado: (2019)

Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions
por: Fam, Jiang Ming, et al.
Publicado: (2017)

One-year efficacy and safety of everolimus-eluting bioresorbable scaffolds in the setting of acute myocardial infarction
por: Kim, Yongcheol, et al.
Publicado: (2020)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
por: Gomez‐Lara, Josep, et al.
Publicado: (2021)

Long-term follow-up of therapeutic efficacy of everolimus-eluting bioresorbable vascular scaffold in comparison to everolimus-eluting stent in treatment of chronic total occlusion guided by intracoronary imaging
por: Eltahlawi, Mohammad Abdallah, et al.
Publicado: (2020)

Bioresorbable Vascular Scaffold Use in a Case of In-stent Restenosis
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k7gbb573uninek7m49rd20tn4a